___

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
• Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181-191.
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consen- sus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19- 25.
• Huang A, Brennan K, Azziz R. Prevalence of hyperandr- ogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010;93:1938-1941.
• Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50:113- 116.
• Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995;80:3788- 3790.
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogen- esis. Endocrine Rev 1997;18:774e800.
• Franks S, Mason H & Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 2000;163: 49e52.
• Butzow TL, Moilanen JM, Lehtovirta M, et al. Serum and follicular fluid leptin during in vitro fertilization: re- lationship among leptin increase, body fat mass, and reduced ovarian response. J Clin Endocrinol Metab 1999;84:3135–3139.
• Alebić MS, Bulum T, Stojanović N, Duvnjak L. Defini- tion of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria. Endocrine 2014 [Epub ahead of print].
• Kashar-Miller M, Azziz R. Heritability and the risk of de- veloping androgen excess. J Steroid Biochem Mol Biol 1999;69:261-268.
• NN Joe-kechebelu, SU Mbamara, JI Ikechebelu. Famil- ial trend in polycystic ovarian syndrome: Report of two cases. Ann Afr Med 2013;12:182-184.
• Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic ap- proach. Front Horm Res 2013;40:1-21.
• “BMI classification”. World Health Organization. Re- trieved 15 February 2014.
• Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome. International Journal of Obesity & Related Metabolic Disorders 2002; 26: 883e896.
• Yildiz BO, Knochenhauer ES, Azziz R. Impact of obe- sity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93:162-168.
• Frary JM, Bjerre KP, Glintborg D, Ravn P. The effect of dietary carbohydrates in women with polycystic ovary syndrome. Minerva Endocrinol 2014 [Epub ahead of print].
• Patel SM, Nestler JE. Fertility in polycystic ovary syn- drome. Endocrinol Metab Clin North Am 2006;35:137- 155.
• Thessaloniki EA-SPCWG. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 2008; 89: 505-522.
• Legro RS, Chiu P, Kunselman AR, et al. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J Clin Endocrinol Metab 2005;90:2571–2579.
• Legro RS. Obesity and PCOS: implications for diag- nosis and treatment. Semin Reprod Med 2012;30:496- 506.
• Clark AM, Thornley B, Tomlinson L, et al. Weight loss in obese infertile women results in improvement in re- productive outcome for all forms of fertility treatment. Human Reproduction 1998; 13: 1502e -1505.
• Hart R, Norman R. Polycystic ovarian syndrome--prog- nosis and outcomes. Best Pract Res Clin Obstet Gyn- aecol 2006;20:751-778.
• Perales-Puchalt A, Legro RS. Ovulation induction in women with polycystic ovary syndrome. Steroids 2013;78:767-772.
• Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev 2013;14:95-109.
• Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg 2009;19:1605-1611.
• Baillargeon JP, Jakubowicz DJ, Iuorno MJ, et al. Effects of metformin and rosiglitazone, alone and in combina- tion, in non-obese women with polycystic ovary syn- drome and normal indices of insulin sensitivity. Fertil Steril 2004;82:893-902.
• Carmina E, Lobo RA. Does metformin induce ovulation in normoandrogenic anovulatory women? Am J Obstet Gynecol 2004;191:15801584.
• Tang T, Lord JM, Norman RJ, et al. Insulin-sensitizing drugs (metformin, rosiglitazone, pioglitazone, D-chiro- inositol) for women with polycystic ovary syndrome, oli- go-amenorrhoea and subfertility. Cochrane Database Syst Rev 2012;5:CD003053.
• Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-556.
• A Ayaz, Y Alwan, and MU Farooq. Efficacy of combined metformin–clomiphene citrate in comparison with clo- miphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS). J Med Life 2013;6:199-201.
• Neveu N, Granger L, St-Michel P, Lavoie HB. Com- parison of clomiphene citrate, metformin, or the com- bination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycys- tic ovary syndrome. Fertil Steril 2007 ;87:113-120.
• Ota H, Goto T, Yoshioka T, Ohyama N. Success- ful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome. Fertil Steril 2008;90:709-713.
• Ma LK, Jin LN, Yu Q, Xu L. Effect of lifestyle adjust- ment, metformin and rosiglitazone in polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2007;42:294- 297.
• Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syn- drome. Fertil Steril 2006;85:428-435.
• Zhang CL, Gao HY, Zhao ZG, Jia P. Effect of rosigli- tazone on ovulation induction in women with polycys- tic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2004;39:173-175.
• Messinis IE. Ovulation induction: a mini review. Hum Reprod 2005; 20: 2688e2697.
• Clark JH, Markaverich BM. The agonist-antag- onist properties of clomiphene. Pharmacol Ther 1981;15:467-519.
• Hammod MG, Halme JK, Talbert LM. Factors effecting pregnancy rate in clomiphene citrate induction of ovula- tion. Obstet Gynecol 1983;62:196–202.
• Kalra A, Nair S, Rai L. Association of obesity and insulin resistance with dyslipidemia in Indian women with poly- cystic ovarian syndrome. Indian J Med Sci 2006;60:44- 53.
• MacDougall MJ, Tan SL, Hall V, et al. Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril 1994;61:1052-1057.
• Asch RH, Greenblatt RB. Update on the safety and ef- ficacy of clomiphene citrate as a therapeutic agent. J Reprod Med 1976;17:175-180.
• Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-776.
• Mitwally MF, Casper RF. Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil Steril 2005; 83: 229e231.
• Casper RF, Mitwally MF. Use of the aromatase in- hibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol 2011;54:685-695.
• Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006;85:277-284.
• Casper RF, Mitwally MF. Use of the aromatase in- hibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol 2011;54:685-695.
• Misso ML, Wong JL, Teede HJ, et al. Aromatase inhibi- tors for PCOS: a systematic review and meta-analysis. Hum Reprod Update 2012;18:301-312.
• Nugent D, Vandekerckhove P, Hughes E, et al. Gonad- otrophin therapy for ovulation induction in subfertility kjassociated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2000; 4: CD000410.
• Christin-Maitre S, Hugues JN. A comparative random- ized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 2003;18:1626-1631.
• Homburg R, Hendriks ML, König TE, et al. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with poly- cystic ovary syndrome: A prospective randomized mul- tinational study. Hum Reprod 2012;27:468-473.
• Stein IF, Cohen MR, Elson R. Results of bilateral ovar- ian wedge resevtion in 47 cases of sterility; 20 year end results; 75 cases of bilateral polycystic ovaries. Am J Obstet Gynecol 1949;58:267-274.
• Badawy A, Khiary M, Ragab A, et al. Ultrasound-guided transvaginal ovarian needle drilling (UTND) for treat- ment of polycystic ovary syndrome: A randomized con- trolled trial. Fertil Steril 2009; 91:1164-1167.
• Zhu WJ, Fu ZH, Chen XM, et al. Ultrasound-guided transvaginal ovarian interstitial laser treatment in patients with polycystic ovary syndrome: A laser dose-finding study. Zhonghua Fu Chan Ke Za Zhi 2009;44:27-31.
• Braidy C, Nazac A, Legendre G, et al. Comparison of fertiloscopy versus laparoscopy in the exploration of the infertility: Analysis of the literature. J Gynecol Ob- stet Biol Reprod 2014; pii: S0368-2315(14)00085-4.
• R Homburg. Laparoscopic Ovarian Drilling. Ovulation Induction and Controlled Ovarian Stimulation, 2nd edi- tion, Springer 2014;XI:1-2.
• Farguhar C, Lilford RJ, Marjoribanks J, Vandekerck- hove P. Laparoscopic ‘drilling’ by diathermy or la- ser for ovulation induction in anovulatory polycys- tic ovary syndrome. Cochrane Databsae Syst Rev 2007;3:CD001122.
• Roy KK, Baruah J, Sharma A, et al. A prospective ran- domized trial comparing the clinical and endocrino- logical outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian dis- ease resistant to ovulation induction with clomiphene citrate. Arch Gynecol Obstet 2010;281:939-944.
• Bhagavath B, Carson SA. Ovulation induction in wom- en with polycystic ovary syndrome: an update. Am J Obstet Gynecol 2012;206:195-198.
• Youssef H, Atallah MM. Unilateral ovarian drilling in polycystic ovarian syndrome: a prospective random- ized study. Reprod Biomed Online 2007;15:457-462.
• Mercorio F, Mercorio A, Di Spiezio Sardo A, et al. Eval- uation of ovarian adhesion formation after laparoscopic ovarian drilling by second-look minilaparoscopy. Fertil Steril 2008;89:1229-1233.
• Seow KM, Juan CC, Hwang JL, Ho LT. Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med 2008;2:101-110.
• Wang XX, Luan CX, Zhang W, Hu SM. Pregnancy out- comes of in vitro fertilization and embryo transfer in in- fertile women with polycystic ovarian syndrome. Zhon- ghua Fu Chan Ke Za Zhi 2012;47:730-733.
• Abu Hashim H, Wafa A, El Rakhawy M. Combined metformin and clomiphene citrate versus highly puri- fied FSH for ovulation induction in clomiphene-resistant PCOS women: A randomised controlled trial. Gynecol Endocrinol 2011;27:190-196.
• Vause TD, Cheung AP, Sierra S, et al. Society of Obste- tricians and Gynecologists of Canada. Ovulation induc- tion in polycystic ovary syndrome. J Obstet Gynaecol Can 20;32:495-502.